News
-
-
-
-
COMMUNIQUÉ DE PRESSE
KALRAY ACHIEVES SIGNIFICANT IMPROVEMENT IN 2023 ANNUAL RESULTS
Kalray (Euronext Growth Paris: ALKAL) announces strong financial results for 2023, with consolidated revenue up 57% to €25.8 million, gross margin at 67%, and significant EBITDA improvement. Strategic collaborations with Arm in the AI market show promising growth potential -
-
COMMUNIQUÉ DE PRESSE
Blue Cap AG publishes 2023 annual report and proposes dividend of EUR 0.65 per share
Blue Cap AG publishes 2023 annual report with EUR 273.3 million revenue and proposes dividend of EUR 0.65 per share. NAV at EUR 112.3 million. Forecast for 2024 includes revenue of EUR 270-290 million -
-
COMMUNIQUÉ DE PRESSE
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
Kuros Biosciences reports strong Q1 2024 performance with 155% increase in direct MagnetOs sales. FDA clearance for MagnetOs Putty and positive EBITDA. Joe Ross appointed SVP Marketing -
-
COMMUNIQUÉ DE PRESSE
Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth
Evotec SE announces fiscal year 2023 results with focus on profitable growth. Priority reset to drive annual EBITDA improvement greater than €40m. New reporting structure planned for Q1 2024
